Instil Bio, Inc. (TIL)
7.995
+0.22
(+2.76%)
USD |
NASDAQ |
Feb 13, 16:00
7.995
0.00 (0.00%)
After-Hours: 16:58
Instil Bio Cash from Investing (Quarterly) : 8.447M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 38.84M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -330.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.56M |
| Cash from Financing (Quarterly) | 0.378M |
| Free Cash Flow | -40.10M |
| Free Cash Flow Per Share (Quarterly) | -1.562 |
| Free Cash Flow to Equity (Quarterly) | -10.59M |
| Free Cash Flow to Firm (Quarterly) | -8.975M |
| Free Cash Flow Yield | -75.96% |